Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis.
- Published In:
- The New England journal of medicine, 391(17), 1573-1583 (2024)
- Authors:
- Bliddal, Henning, Bays, Harold, Czernichow, Sébastien, Uddén Hemmingsson, Joanna, Hjelmesæth, Jøran, Hoffmann Morville, Thomas, Koroleva, Anna, Skov Neergaard, Jesper, Vélez Sánchez, Patricia, Wharton, Sean, Wizert, Alicja, Kristensen, Lars E
- Database ID:
- RPEP-07867
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07867APA
Bliddal, Henning; Bays, Harold; Czernichow, Sébastien; Uddén Hemmingsson, Joanna; Hjelmesæth, Jøran; Hoffmann Morville, Thomas; Koroleva, Anna; Skov Neergaard, Jesper; Vélez Sánchez, Patricia; Wharton, Sean; Wizert, Alicja; Kristensen, Lars E. (2024). Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis.. The New England journal of medicine, 391(17), 1573-1583. https://doi.org/10.1056/NEJMoa2403664
MLA
Bliddal, Henning, et al. "Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis.." The New England journal of medicine, 2024. https://doi.org/10.1056/NEJMoa2403664
RethinkPeptides
RethinkPeptides Research Database. "Once-Weekly Semaglutide in Persons with Obesity and Knee Ost..." RPEP-07867. Retrieved from https://rethinkpeptides.com/research/bliddal-2024-onceweekly-semaglutide-in-persons
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.